- Home
- SRCE vs GPCR Comparison
SRCE vs GPCR Comparison
Compare SRCE & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRCE
- GPCR
- Stock Information
- Founded
- SRCE 1863
- GPCR 2016
- Country
- SRCE United States
- GPCR United States
- Employees
- SRCE N/A
- GPCR N/A
- Industry
- SRCE Major Banks
- GPCR
- Sector
- SRCE Finance
- GPCR
- Exchange
- SRCE Nasdaq
- GPCR Nasdaq
- Market Cap
- SRCE 1.5B
- GPCR 1.2B
- IPO Year
- SRCE N/A
- GPCR 2023
- Fundamental
- Price
- SRCE $60.65
- GPCR $28.95
- Analyst Decision
- SRCE Hold
- GPCR Strong Buy
- Analyst Count
- SRCE 4
- GPCR 8
- Target Price
- SRCE $71.25
- GPCR $69.57
- AVG Volume (30 Days)
- SRCE 77.9K
- GPCR 919.9K
- Earning Date
- SRCE 10-23-2025
- GPCR 11-12-2025
- Dividend Yield
- SRCE 2.55%
- GPCR N/A
- EPS Growth
- SRCE 14.53
- GPCR N/A
- EPS
- SRCE 6.01
- GPCR N/A
- Revenue
- SRCE $405,363,000.00
- GPCR N/A
- Revenue This Year
- SRCE $17.85
- GPCR N/A
- Revenue Next Year
- SRCE $1.85
- GPCR N/A
- P/E Ratio
- SRCE $10.10
- GPCR N/A
- Revenue Growth
- SRCE 9.59
- GPCR N/A
- 52 Week Low
- SRCE $52.14
- GPCR $13.22
- 52 Week High
- SRCE $68.13
- GPCR $42.57
- Technical
- Relative Strength Index (RSI)
- SRCE 50.93
- GPCR 60.25
- Support Level
- SRCE $58.79
- GPCR $25.59
- Resistance Level
- SRCE $61.83
- GPCR $27.49
- Average True Range (ATR)
- SRCE 1.50
- GPCR 1.56
- MACD
- SRCE 0.22
- GPCR -0.32
- Stochastic Oscillator
- SRCE 76.11
- GPCR 61.20
About SRCE 1st Source Corporation
1st Source Corp, along with its subsidiary, offers banking services. The bank provides Commercial, Agricultural, and Real Estate Loans, which are given to privately owned business clients mainly located within the regional market areas, Consumer Services that consist of the full range of consumer banking products and services, Trust and Wealth Advisory Services, and Insurance services to individuals and business clients. Its Specialty Finance Group offers financing services for construction equipment, new and pre-owned private and cargo aircraft, and various vehicle types for fleet purposes.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.